Absci (ABSI) Debt to Equity (2020 - 2025)

Absci's (ABSI) quarterly Debt to Equity came in at $0.06 in Q3 2025, up 469.21% year-on-year from $0.01 in Q3 2024, and down 18.19% quarter-over-quarter from $0.07 in Q2 2025.

Absci (ABSI) Debt to Equity (2020 - 2025) Analysis & Trends

Absci has disclosed Debt to Equity across 6 years of filings, most recently posting $0.06 for Q3 2025.

  • Debt to Equity for Q3 2025 came in at $0.06, up 469.21% year-over-year; the trailing twelve-month figure through Sep 2025 was $0.06 (up 469.21% YoY), and the FY2024 annual result was $0.08, down 20.87% from the prior year.
  • Debt to Equity came in at $0.06 for Q3 2025 at Absci, down from $0.07 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.1 in Q4 2023 to a low of -$0.03 in Q2 2021.
  • The 5-year median for Debt to Equity is $0.03 (2023), against an average of $0.03.
  • Across the five-year window, Debt to Equity jumped 1715.4% in 2023 and sank 62.11% in 2024, its largest moves.
  • Absci's Debt to Equity stood at $0.0 in 2021, then surged by 847.67% to $0.03 in 2022, then jumped by 239.65% to $0.1 in 2023, then declined by 20.87% to $0.08 in 2024, then dropped by 22.08% to $0.06 in 2025.
  • The last three Debt to Equity figures came in at $0.06 (Q3 2025), $0.07 (Q2 2025), and $0.07 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.06
Jun 30, 2025 0.07
Mar 31, 2025 0.07
Dec 31, 2024 0.08
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.02
Dec 31, 2023 0.10
Sep 30, 2023 0.03
Jun 30, 2023 0.03
Mar 31, 2023 0.03
Dec 31, 2022 0.03
Sep 30, 2022 0.02
Jun 30, 2022 0.02
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 -0.03
Dec 31, 2020 -0.05